Cargando…

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology

Detalles Bibliográficos
Autores principales:	Jayachandran, Priya, Desikan, Rajat, Krishnaswami, Sriram, Hennig, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681474/ https://www.ncbi.nlm.nih.gov/pubmed/37849052 http://dx.doi.org/10.1002/psp4.13066

Ejemplares similares

CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision
por: Rowland Yeo, Karen, et al.
Publicado: (2021)

Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021)

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration
por: Trame, Mirjam N., et al.
Publicado: (2018)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Barriers to global pharmacometrics: educational challenges and opportunities across the globe
por: Michelet, Robin, et al.
Publicado: (2023)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
por: Hennig, Stefanie, et al.
Publicado: (2019)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Time to Expect More From Pharmacometrics
por: Barrett, Jeffrey S.
Publicado: (2020)

Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches
por: Schmidt, Stephan, et al.
Publicado: (2019)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities
por: Kaibara, Atsunori, et al.
Publicado: (2022)

Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence
por: Frey, Nicolas, et al.
Publicado: (2021)

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
por: Chaturvedula, Ayyappa, et al.
Publicado: (2019)

Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020)

R and nlmixr as a gateway between statistics and pharmacometrics
por: Fidler, Matthew, et al.
Publicado: (2021)

CYTOCON DB: A versatile database of human cell and molecule concentrations for accelerating model development
por: Desikan, Rajat, et al.
Publicado: (2023)

CPT: Pharmacometrics and Systems Pharmacology
por: van der Graaf, Piet H
Publicado: (2012)

CPT: Pharmacometrics & Systems Pharmacology
Publicado: (2013)

Variable or variate? A conundrum in pharmacometrics exposure–response models
por: Grisic, Ana‐Marija, et al.
Publicado: (2022)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics
por: Moore, Helen
Publicado: (2019)

Tutorials on the Foundations of Pharmacometrics and Systems Pharmacology
por: Friberg, L E
Publicado: (2013)

Precision Medicine in Pharmacometrics and Systems Pharmacology
por: Li, L
Publicado: (2017)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

CPT: Pharmacometrics & Systems Pharmacology 2.0
por: Mentré, France
Publicado: (2019)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
por: Swat, MJ, et al.
Publicado: (2015)

Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction
por: Craig, M, et al.
Publicado: (2016)

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Dr. Hartmut Derendorf, PhD, a world‐renowned expert in pharmacokinetics and pharmacometrics (1953–2020)
por: Sinha, Vikram, et al.
Publicado: (2021)

Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling
por: Hofmann, Daniela, et al.
Publicado: (2021)

Advances in quantitative methods and modeling for complex generic drugs and opportunities to hybridize learnings between innovator and generic drug developers
por: Jayachandran, Priya
Publicado: (2023)

A Philosophical Framework for Integrating Systems Pharmacology Models Into Pharmacometrics
por: Duffull, SB
Publicado: (2016)

Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

Efficient and relevant stepwise covariate model building for pharmacometrics
por: Svensson, Robin J., et al.
Publicado: (2022)

CPT: Pharmacometrics & Systems Pharmacology Publishes Its 100th Article
por: van der Graaf, P H, et al.
Publicado: (2014)

Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology
por: Li, L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7bg9jb6hbc3cceqr134olqrphg